A non-exclusive commercial license under PATENT RIGHTS and a non-exclusive Commericial license for the use of biological materials for the manufacture, use and use, sale and sale of the products granted and the exercise of the processes granted during the duration of the patent rights. These licences do not include the right to issue sublicensings. (a) a non-exclusive commercial license under PATENT RIGHTS, and LICENSEE is seeking a non-exclusive license in the territory to use biological materials and to practice the aforementioned invention, which falls under PATENT RIGHTS in the United States [and in some countries], and to manufacture, use and sell in the commercial market products manufactured in accordance with the patents. HARVARD wishes to grant license to LICENSEE under the terms of this agreement. (a) « Statement of Policy in Regard to Inventions, Patents and Copyrights, » August 10, 1998, Public Law 96-517, Public Law 98-620 and HARVARD`s obligations under agreements with other sponsors of research. Any law that is greater than the law authorized by public law 96-517 or by public law 98-620 is subject to an amendment to the extent necessary to comply with the provisions of these statutes. . (d) all of these reports are treated confidentially by HARVARD, unless required by law; Harvard may, however, include annual royalties paid in its regular reports. 8.2 HARVARD EXPRESSLY DISCLAIMS ALL IMPLICIT OR EXPLICIT SAFEGUARDS AND DOES NOT PROVIDE EXPLICIT OR IMPLIED GUARANTEES AS TO WHETHER THE MARKET IS ACCESSIBLE OR APPROPRIATE TO A PARTICULAR PURPOSE OF PATENT RIGHTS, BIOLOGICAL MATERIALS OR INFORMATION PROVIDED BY HARVARD, PROCESSES OR PRODUCTS GRANTED IN ACCORDANCE WITH THIS AGREEMENT. In addition, HARVARD has not conducted an investigation and does not guarantee that the biological materials it has supplied or the methods used to manufacture or use these materials are exempt from liability in the event of patent infringement.
8.6 LICENSEE shall not use the name or insignia of HARVARD or its adaptation or the name of any of Harvard`s inventors without prior written permission from HARVARD. 4.3 By January 1 of each calendar year following the entry into force of this agreement, LICENSEE will pay HARVARD the following non-refundable royalties and/or royalties. These payments may be charged on outstanding licence fees due for this calendar year and the reports submitted to license reflect such credit. These payments are not charged on royalties due for a subsequent calendar year. IN WITNESS WHEREOF, the parties executed this agreement by their duly authorized representatives. 8.12 If a competent court subsequently considers that a provision of this agreement is invalid, illegal or unenforceable and that such participation is not quashed in the appeal proceedings, it is deemed to be dissociated from that agreement. All other provisions, rights and obligations are maintained without regard to the separate provision, provided that the other provisions of this agreement are consistent with the intentions of the parties. (e) late payments are estimated at one and a half per cent (1 1/2%) Calculated. $250 per month, depending on the highest value. 8.5 (a) LICENSEE releases HARVARD and its current or former directors, board members, directors, administrators, teachers, professionals, collaborators and agents, as well as their successors, heirs and beneficiaries of the assignment (together the « INDEMNITEES ») from and against any claim, Liability, costs, costs, damage, defect, loss or obligation of any kind or nature (including, but not limited to, reasonable legal fees and other litigation costs and costs) (all « claims » that are based on this contract, arising from or other means related to the agreement, including, but not limited, a reason for measures relating to liability for products, processes or services that are manufactured , used or sold under a right, licence or licence granted under this Agreement.